Cannabix Technologies to Market Marijuana Breath Test at Major Industry Conference

Cannabix Technologies ( (TSE:BLO) ) has provided an update.

Cannabix Technologies Inc. announced its participation in the National Drug and Alcohol Screening Association conference in Florida, alongside Omega Laboratories, to market their Marijuana Breath Test (MBT). This follows a significant milestone where Omega Laboratories validated the MBT, which can detect recent marijuana use by quantifying THC and other cannabinoids in breath aerosols. The company is preparing to scale its operations to meet anticipated demand, positioning itself as a leader in the drug detection industry.

More about Cannabix Technologies

Cannabix Technologies Inc. is a developer of marijuana and alcohol breath testing technologies aimed at various sectors including workplaces and law enforcement. The company focuses on detecting recent marijuana use through breath testing, which is crucial for employers and law enforcement agencies. Additionally, Cannabix has developed the Breath Logix autonomous alcohol screening device to enhance alcohol safety and monitoring.

YTD Price Performance: 56.67%

Average Trading Volume: 100,570

Technical Sentiment Signal: Sell

Current Market Cap: $44M

See more insights into BLO stock on TipRanks’ Stock Analysis page.